Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thomas Bernd Dschietzig"'
Publikováno v:
ESC Heart Failure, Vol 7, Iss 6, Pp 3274-3277 (2020)
Externí odkaz:
https://doaj.org/article/3e2a891604094d40bbe242313788cb08
Autor:
Thomas Bernd Dschietzig, Karl-Heinz Kellner, Katrin Sasse, Felix Boschann, Robert Klüsener, Jana Ruppert, Franz Paul Armbruster, Dragic Bankovic, Andreas Meinitzer, Veselin Mitrovic, Christoph Melzer
Publikováno v:
Kidney & Blood Pressure Research, Vol 44, Iss 4, Pp 765-776 (2019)
Background: Kynurenine, a metabolite of the L-tryptophan pathway, plays a pivotal role in neuro-inflammation, cancer immunology, and cardiovascular inflammation, and has been shown to predict cardiovascular events. Objectives: It was our objective to
Externí odkaz:
https://doaj.org/article/b0f0aff49684458a903f24bf0de0afdc
Autor:
Augustinas Bausys, Juste Maneikyte, Bettina Leber, Jennifer Weber, Nicole Feldbacher, Kestutis Strupas, Thomas Bernd Dschietzig, Peter Schemmer, Philipp Stiegler
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 21, p 11417 (2021)
Objective. Ischemia-reperfusion injury (IRI) is inevitable after kidney transplantation (KT), impairing outcomes. Relaxin-2 (RLX) is a promising insulin-related peptide hormone that protects against renal IRI in rodents, although large animal models
Externí odkaz:
https://doaj.org/article/5dec60fed4cf4a3297d0a50579bd3df9
Autor:
Thomas Bernd Dschietzig, Katharina Krause-Relle, Maud Hennequin, Karoline von Websky, Jan Rahnenführer, Jana Ruppert, Hans Jürgen Grön, Franz Paul Armbruster, Ross A. D. Bathgate, Joerg R. Aschenbach, Wolf-Georg Forssmann, Berthold Hocher
Publikováno v:
Kidney & Blood Pressure Research, Vol 40, Iss 1, Pp 77-88 (2015)
Background/Aims: In diabetic nephropathy (DN), the current angiotensin-II-blocking pharmacotherapy is frequently failing. For diabetic cardiomyopathy (DC), there is no specific remedy available. Relaxin-2 (Rlx) - an anti-fibrotic, anti-inflammatory,
Externí odkaz:
https://doaj.org/article/7ef09891ceef4b01963b9c4d39fdd4b7
Autor:
Kęstutis Strupas, Nicole Feldbacher, Jennifer Weber, Bettina Leber, Philipp Stiegler, Peter Schemmer, Thomas Bernd Dschietzig, Juste Maneikyte, Augustinas Bausys
Publikováno v:
International journal of molecular sciences, Basel : MDPI, 2021, vol. 22, iss. 21, art. no. 11417, p. 1-16
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences, Vol 22, Iss 11417, p 11417 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 21
International Journal of Molecular Sciences, Vol 22, Iss 11417, p 11417 (2021)
Objective. Ischemia-reperfusion injury (IRI) is inevitable after kidney transplantation (KT), impairing outcomes. Relaxin-2 (RLX) is a promising insulin-related peptide hormone that protects against renal IRI in rodents, although large animal models
Autor:
Thomas Bernd Dschietzig
Publikováno v:
British Journal of Pharmacology. 158:S90-S91